Bryan Lawlis V - 14 Jan 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Director
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 14 Jan 2022
Net transactions value: -$213,138
Form type: 4
Filing time: 19 Jan 2022, 17:34:31 UTC
Previous filing: 09 Jun 2021
Next filing: 18 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Options Exercise	$159,205	+4,250	+18%	$37.46	28,220	14 Jan 2022	Direct	F1
transaction	BMRN	Common Stock	Sale	$372,342	-4,250	-15%	$87.61	23,970	14 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Options Exercise	$0	-4,250	-50%	$0.000000	4,250	14 Jan 2022	Common Stock	4,250	$37.46	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.
F2	Reflects the number of options outstanding after the transactions from this specific stock option grant.